Safety Alerts & Recalls

Search all Safety Alerts & Recalls

Latest Alerts

FDA Stops Imports of Ranbaxy Products
The U.S. Food and Drug Administration (FDA) is stopping the import of several drug products produced by the generic drug manufacturer Ranbaxy Laboratories, Ltd.  The FDA is concerned that Ranbaxy facilities in India are not following U.S. standards for good manufacturing practices.  Although glimepiride is one of the medications manufactured by Ranbaxy, drug shortages are not expected because, in most instances, there are enough other suppliers that can help meet demand for glimepiride. For more information, please visit: http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/2008/ucm116949.htm
Learn More

FDA Stops Imports of Ranbaxy Products
The U.S. Food and Drug Administration (FDA) is stopping the import of several drug products produced by the generic drug manufacturer Ranbaxy Laboratories, Ltd.  The FDA is concerned that Ranbaxy facilities in India are not following U.S. standards for good manufacturing practices.  Although isotretinoin is one of the medications manufactured by Ranbaxy, drug shortages are not expected because, in most instances, there are enough other suppliers that can help meet demand for isotretinoin. For more information, please visit: http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/2008/ucm116949.htm
Learn More

Date Published Title Drug Source
2008-09-18 FDA Stops Imports of Ranbaxy Products Glimepiride FDA
2008-09-18 FDA Stops Imports of Ranbaxy Products Isotretinoin FDA
2008-09-18 FDA Stops Imports of Ranbaxy Products Lamivudine FDA
2008-09-18 FDA Stops Imports of Ranbaxy Products Loratadine FDA
2008-09-18 FDA Stops Imports of Ranbaxy Products Metformin FDA
2008-09-18 FDA Stops Imports of Ranbaxy Products Nefazodone FDA
2008-09-18 FDA Stops Imports of Ranbaxy Products Nitrofurantoin FDA
2008-09-18 FDA Stops Imports of Ranbaxy Products Ofloxacin FDA
2008-09-18 FDA Stops Imports of Ranbaxy Products Pravastatin FDA
2008-09-18 FDA Stops Imports of Ranbaxy Products Ranitidine FDA
2008-09-18 FDA Stops Imports of Ranbaxy Products Simvastatin FDA
2008-09-18 FDA Stops Imports of Ranbaxy Products Terazosin FDA
2008-09-18 FDA Stops Imports of Ranbaxy Products Valacyclovir FDA
2008-09-18 FDA Stops Imports of Ranbaxy Products Zidovudine FDA
2008-09-18 FDA Stops Imports of Ranbaxy Products Ganciclovir FDA
2008-09-18 Long-term use of proton pump inhibitors (PPIs) may increase risk of fractures Esomeprazole MediGuard CRT
2008-09-18 Long-term use of proton pump inhibitors (PPIs) may increase risk of fractures Lansoprazole MediGuard CRT
2008-09-18 Long-term use of proton pump inhibitors (PPIs) may increase risk of fractures Omeprazole MediGuard CRT
2008-09-18 Long-term use of proton pump inhibitors (PPIs) may increase risk of fractures Pantoprazole MediGuard CRT
2008-09-18 Long-term use of proton pump inhibitors (PPIs) may increase risk of fractures Rabeprazole MediGuard CRT
Back to Consumer Med Safety